Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3008891017 | Dabrafenib 50 mg capsule | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3008975019 | Dabrafenib 50 mg capsule (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3488334018 | Product containing dabrafenib 50 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3497228014 | Dabrafenib 50 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3497229018 | Product containing dabrafenib 50 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570911016 | Product containing only dabrafenib 50 mg/1 each oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570912011 | Product containing only dabrafenib 50 mg/1 each oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3677918012 | Product containing precisely dabrafenib (as dabrafenib mesylate) 50 milligram/1 each conventional release oral capsule | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3677919016 | Dabrafenib (as dabrafenib mesylate) 50 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3677920010 | Product containing precisely dabrafenib (as dabrafenib mesylate) 50 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3726284015 | Dabrafenib (as dabrafenib mesilate) 50 mg oral capsule | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3726285019 | Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 87487001000001117 | Dabrafenib 50mg capsules | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing dabrafenib | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Dabrafenib mesilate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Dabrafenib mesilate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance | Dabrafenib | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Dabrafenib mesilate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing dabrafenib in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing only dabrafenib in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Dabrafenib | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | capsule.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Dabrafenib | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Conventional release oral capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has specific active ingredient | Dabrafenib mesilate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Dabrafenib | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has dispensed dose form | Capsule | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance | Dabrafenib | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tafinlar 50mg capsules (GlaxoSmithKline UK Ltd) | Is a | True | Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Dabrafenib 50mg capsules 28 capsule | Has VMP | True | Product containing precisely dabrafenib (as dabrafenib mesilate) 50 milligram/1 each conventional release oral capsule (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets